688212 澳华内镜
已收盘 12-05 15:00:01
资讯
新帖
简况
澳华内镜：12月3日高管顾小舟减持股份合计10万股
中金财经 · 12-04 20:17
澳华内镜：12月3日高管顾小舟减持股份合计10万股
澳华内镜：12月2日高管顾小舟减持股份合计20万股
证券之星 · 12-03 20:03
澳华内镜：12月2日高管顾小舟减持股份合计20万股
澳华内镜：12月1日高管顾小舟减持股份合计20万股
证券之星 · 12-02
澳华内镜：12月1日高管顾小舟减持股份合计20万股
澳华内镜：11月24日高管顾小舟减持股份合计17.03万股
证券之星 · 11-25
澳华内镜：11月24日高管顾小舟减持股份合计17.03万股
【机构调研记录】汇添富基金调研冰轮环境、澳华内镜等5只个股（附名单）
证券之星 · 11-17
【机构调研记录】汇添富基金调研冰轮环境、澳华内镜等5只个股（附名单）
【机构调研记录】上银基金调研澳华内镜、金达威
证券之星 · 11-17
【机构调研记录】上银基金调研澳华内镜、金达威
澳华内镜：11月13日接受机构调研，富国基金、中信资管等多家机构参与
证券之星 · 11-14
澳华内镜：11月13日接受机构调研，富国基金、中信资管等多家机构参与
11月10日澳华内镜涨5.75%，富国精准医疗混合A基金重仓该股
证券之星 · 11-10
11月10日澳华内镜涨5.75%，富国精准医疗混合A基金重仓该股
澳华内镜涨5.75%，华安证券一个月前给出“买入”评级
证券之星 · 11-10
澳华内镜涨5.75%，华安证券一个月前给出“买入”评级
每周股票复盘：澳华内镜（688212）拟增加经营范围并修订章程
证券之星 · 11-09
每周股票复盘：澳华内镜（688212）拟增加经营范围并修订章程
每周股票复盘：澳华内镜（688212）股东户数增41.52%，Q3营收增10.37%
证券之星 · 11-02
每周股票复盘：澳华内镜（688212）股东户数增41.52%，Q3营收增10.37%
澳华内镜(688212.SH)实际控制人之一顾小舟拟减持不超1.93%股份
智通财经 · 10-31
澳华内镜(688212.SH)实际控制人之一顾小舟拟减持不超1.93%股份
澳华内镜(688212)9月30日股东户数0.55万户，较上期增加41.52%
证券之星 · 10-29
澳华内镜(688212)9月30日股东户数0.55万户，较上期增加41.52%
图解澳华内镜三季报：第三季度单季净利润同比下降148.44%
证券之星 · 10-29
图解澳华内镜三季报：第三季度单季净利润同比下降148.44%
每周股票复盘：澳华内镜（688212）股东减持258.18万股占总股本1.9172%
证券之星 · 10-19
每周股票复盘：澳华内镜（688212）股东减持258.18万股占总股本1.9172%
10月14日澳华内镜跌5.64%，富国精准医疗混合A基金重仓该股
证券之星 · 10-14
10月14日澳华内镜跌5.64%，富国精准医疗混合A基金重仓该股
股市必读：9月29日澳华内镜现6笔折价10.03%的大宗交易 合计成交1651.07万元
证券之星 · 09-30
股市必读：9月29日澳华内镜现6笔折价10.03%的大宗交易 合计成交1651.07万元
华安证券：给予澳华内镜买入评级
证券之星 · 09-29
华安证券：给予澳华内镜买入评级
澳华内镜公布国际专利申请：“内窥镜系统的光源装置及内窥镜系统”
证券之星 · 09-23
澳华内镜公布国际专利申请：“内窥镜系统的光源装置及内窥镜系统”
每周股票复盘：澳华内镜（688212）现7笔大宗交易机构净买入1392.89万元
证券之星 · 09-21
每周股票复盘：澳华内镜（688212）现7笔大宗交易机构净买入1392.89万元
加载更多
公司概况
公司名称：
上海澳华内镜股份有限公司
所属行业：
专用设备制造业
上市日期：
2021-11-15
主营业务：
上海澳华内镜股份有限公司的主营业务是电子内窥镜设备及内窥镜诊疗手术耗材研发、生产和销售。公司的主要产品是内窥镜设备、内窥镜诊疗耗材、内窥镜维修服务。
发行价格：
22.50
{"stockData":{"symbol":"688212","market":"SH","secType":"STK","nameCN":"澳华内镜","latestPrice":47.69,"timestamp":1764918001000,"preClose":46.87,"halted":0,"volume":1036172,"delay":0,"changeRate":0.0175,"floatShares":135000000,"shares":135000000,"eps":-0.5376,"marketStatus":"已收盘","change":0.82,"latestTime":"12-05 15:00:01","open":46.87,"high":47.91,"low":46.53,"amount":48961400,"amplitude":0.0294,"askPrice":47.69,"askSize":6,"bidPrice":47.68,"bidSize":67,"shortable":0,"etf":0,"ttmEps":-0.5376,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":5,"adr":0,"adjPreClose":46.87,"symbolType":"stock_kcb","openAndCloseTimeList":[[1764898200000,1764905400000],[1764910800000,1764918000000]],"highLimit":51.56,"lowLimit":42.18,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":134665250,"isCdr":false,"pbRate":5.16,"roa":"--","roe":"--","epsLYR":0.16,"committee":0.141509,"marketValue":6422000000,"turnoverRate":0.0077,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-12-08。","afterMarket":{"amount":0,"volume":0,"close":47.69,"buyVolume":0,"sellVolume":0,"time":1764920037768,"indexStatus":"已收盘 12-05 15:30:00","preClose":46.87},"floatMarketCap":6422000000},"requestUrl":"/m/hq/s/688212","defaultTab":"news","newsList":[{"id":"2588813078","title":"澳华内镜：12月3日高管顾小舟减持股份合计10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588813078","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588813078?lang=zh_cn&edition=full","pubTime":"2025-12-04 20:17","pubTimestamp":1764850647,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月4日市场公开信息、上市公司公告及交易所披露数据整理，澳华内镜最新董监高及相关人员股份变动情况：2025年12月3日公司董事顾小舟共减持公司股份10.0万股，占公司总股本为0.0743%。变动期间公司股价下跌0.02%，12月3日当日收盘报46.82元。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202512/04/20251204180995.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202512/04/20251204180995.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251204/31845221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0251","688212"],"gpt_icon":0},{"id":"2588458210","title":"澳华内镜：12月2日高管顾小舟减持股份合计20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588458210","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588458210?lang=zh_cn&edition=full","pubTime":"2025-12-03 20:03","pubTimestamp":1764763390,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月3日市场公开信息、上市公司公告及交易所披露数据整理，澳华内镜最新董监高及相关人员股份变动情况：2025年12月2日公司董事顾小舟共减持公司股份20.0万股，占公司总股本为0.1485%。变动期间公司股价下跌1.18%，12月2日当日收盘报46.83元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300034919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"gpt_icon":0},{"id":"2588030194","title":"澳华内镜：12月1日高管顾小舟减持股份合计20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588030194","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588030194?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:02","pubTimestamp":1764676958,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月2日市场公开信息、上市公司公告及交易所披露数据整理，澳华内镜最新董监高及相关人员股份变动情况：2025年12月1日公司董事顾小舟共减持公司股份20.0万股，占公司总股本为0.1485%。变动期间公司股价上涨0.23%，12月1日当日收盘报47.39元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200034512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"gpt_icon":0},{"id":"2586742058","title":"澳华内镜：11月24日高管顾小舟减持股份合计17.03万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2586742058","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586742058?lang=zh_cn&edition=full","pubTime":"2025-11-25 20:02","pubTimestamp":1764072171,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月25日市场公开信息、上市公司公告及交易所披露数据整理，澳华内镜最新董监高及相关人员股份变动情况：2025年11月24日公司董事顾小舟共减持公司股份17.03万股，占公司总股本为0.1265%。变动期间公司股价下跌0.45%，11月24日当日收盘报46.48元。该股最近90天内共有14家机构给出评级，买入评级9家，增持评级5家；过去90天内机构目标均价为62.36。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500034269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"gpt_icon":0},{"id":"2584057691","title":"【机构调研记录】汇添富基金调研冰轮环境、澳华内镜等5只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2584057691","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584057691?lang=zh_cn&edition=full","pubTime":"2025-11-17 08:02","pubTimestamp":1763337733,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月14日披露的机构调研信息，汇添富基金近期对5家上市公司进行了调研，相关名单如下：1）冰轮环境 调研纪要：公司第三季度营收17.2亿元，同比增长6.88%，归母净利润1.6亿元，同比增长13.54%。前三季度营收48.3亿元，同比下降2.45%；归母净利润4.28亿元，同比下降9.68%。公司拥有有效专利566件，差别化纤维产量占比达27%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700001946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0117","BK0175","BK0151","BK0251","688212","BK0259","000811","BK0188"],"gpt_icon":0},{"id":"2584691787","title":"【机构调研记录】上银基金调研澳华内镜、金达威","url":"https://stock-news.laohu8.com/highlight/detail?id=2584691787","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584691787?lang=zh_cn&edition=full","pubTime":"2025-11-17 08:01","pubTimestamp":1763337666,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月14日披露的机构调研信息，上银基金近期对2家上市公司进行了调研，相关名单如下：1）澳华内镜 调研纪要：Q-400 3D超高清软镜系统在成像技术、操控性和多功能集成方面实现升级，具备3D成像、EDOF、高光谱染色和STCE图像强化功能。上银基金成立于2013年，截至目前，资产管理规模2515.29亿元，排名33/211；资产管理规模1688.89亿元，排名31/211；管理公募基金数106只，排名72/211；旗下公募基金经理21人，排名67/211。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700001878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002626","BK0226","BK0191","BK0197","BK0077","BK0251","688212"],"gpt_icon":0},{"id":"2583571611","title":"澳华内镜：11月13日接受机构调研，富国基金、中信资管等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2583571611","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583571611?lang=zh_cn&edition=full","pubTime":"2025-11-14 17:37","pubTimestamp":1763113024,"startTime":"0","endTime":"0","summary":"答：截至2025年6月30日，公司内窥镜机器人系统已累计投入研发费用6721.4万元。目前，内窥镜机器人系统已完成型检，并准备注册临床入组工作。澳华内镜主营业务：电子内窥镜设备及内窥镜诊疗手术耗材研发、生产和销售。该股最近90天内共有15家机构给出评级，买入评级9家，增持评级6家；过去90天内机构目标均价为62.36。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400028582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"gpt_icon":0},{"id":"2582087823","title":"11月10日澳华内镜涨5.75%，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2582087823","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582087823?lang=zh_cn&edition=full","pubTime":"2025-11-10 16:29","pubTimestamp":1762763354,"startTime":"0","endTime":"0","summary":"证券之星消息，11月10日澳华内镜涨5.75%，收盘报50.97元，换手率3.95%，成交量5.32万手，成交额2.7亿元。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共19家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为34.91亿元，最新净值3.2188，较上一交易日下跌1.61%，近一年上涨33.21%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000020630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"gpt_icon":0},{"id":"2582823038","title":"澳华内镜涨5.75%，华安证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2582823038","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582823038?lang=zh_cn&edition=full","pubTime":"2025-11-10 16:29","pubTimestamp":1762763345,"startTime":"0","endTime":"0","summary":"今日澳华内镜涨5.75%，收盘报50.97元。2025年9月29日，华安证券研究员谭国超,李婵发布了对澳华内镜的研报《上半年业务持续承压，预计下半年修复》，该研报对澳华内镜给出“买入”评级。2025-2027年对应的EPS分别约0.29元、0.69元和1.02元，对应的PE估值分别为165倍、70倍和47倍，维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为14.15%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000020615.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","600909"],"gpt_icon":0},{"id":"2582861104","title":"每周股票复盘：澳华内镜（688212）拟增加经营范围并修订章程","url":"https://stock-news.laohu8.com/highlight/detail?id=2582861104","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582861104?lang=zh_cn&edition=full","pubTime":"2025-11-09 04:07","pubTimestamp":1762632431,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，澳华内镜报收于48.2元，较上周的47.37元上涨1.75%。本周，澳华内镜11月7日盘中最高价报49.6元。本周关注点公司公告汇总：澳华内镜拟增加“计算机软硬件及辅助设备批发”等经营范围，并修订公司章程。本次修订后的经营范围最终以工商登记机关核准为准。该议案已由第二届董事会第二十一次会议审议通过，提交2025年第三次临时股东大会审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001495.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"gpt_icon":0},{"id":"2580799244","title":"每周股票复盘：澳华内镜（688212）股东户数增41.52%，Q3营收增10.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580799244","media":"证券之星","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580799244?lang=zh_cn&edition=full","pubTime":"2025-11-02 04:26","pubTimestamp":1762028773,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，澳华内镜报收于47.37元，较上周的50.59元下跌6.36%。业绩披露要点：2025年第三季度单季度主营收入1.62亿元，同比上升10.37%。公司公告汇总：控股股东顾小舟计划减持不超过260万股，占总股本不超过1.93%。股本股东变化股东户数变动截至2025年9月30日，公司股东户数为5549户，较6月30日增加1628户，增幅41.52%。公司公告汇总2025年第三季度报告2025年第三季度营业收入1.62亿元，同比增长10.37%；前三季度累计营收4.23亿元，同比下降15.57%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200000804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212"],"gpt_icon":0},{"id":"2579495743","title":"澳华内镜(688212.SH)实际控制人之一顾小舟拟减持不超1.93%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2579495743","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579495743?lang=zh_cn&edition=full","pubTime":"2025-10-31 23:04","pubTimestamp":1761923064,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 澳华内镜(688212.SH)发布公告，公司控股股东、实际控制人之一、董事、总经理顾小舟先生计划通过集中竞价交易方式、大宗交易方式合计减持不超过260万股，合计减持比例不超过公司总股本的1.93%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364065.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688212","BK0251"],"gpt_icon":0},{"id":"2579735920","title":"澳华内镜(688212)9月30日股东户数0.55万户，较上期增加41.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579735920","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579735920?lang=zh_cn&edition=full","pubTime":"2025-10-29 17:21","pubTimestamp":1761729708,"startTime":"0","endTime":"0","summary":"证券之星消息，近日澳华内镜披露，截至2025年9月30日公司股东户数为5549.0户，较6月30日增加1628.0户，增幅为41.52%。在医疗器械行业个股中，澳华内镜股东户数低于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.15万户。从股价来看，2025年6月30日至2025年9月30日，澳华内镜区间涨幅为5.67%，在此期间股东户数增加1628.0户，增幅为41.52%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900035626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"gpt_icon":0},{"id":"2579993265","title":"图解澳华内镜三季报：第三季度单季净利润同比下降148.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579993265","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579993265?lang=zh_cn&edition=full","pubTime":"2025-10-29 02:47","pubTimestamp":1761677221,"startTime":"0","endTime":"0","summary":"证券之星消息，澳华内镜2025年三季报显示，公司主营收入4.23亿元，同比下降15.57%；归母净利润-5609.25万元，同比下降250.37%；扣非净利润-6810.11万元，同比下降559.74%；其中2025年第三季度，公司单季度主营收入1.62亿元，同比上升10.37%；单季度归母净利润-1532.72万元，同比下降148.44%；单季度扣非净利润-1634.65万元，同比下降201.16%；负债率31.01%，投资收益17.85万元，财务费用102.86万元，毛利率60.51%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900003152.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212"],"gpt_icon":0},{"id":"2576044937","title":"每周股票复盘：澳华内镜（688212）股东减持258.18万股占总股本1.9172%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576044937","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576044937?lang=zh_cn&edition=full","pubTime":"2025-10-19 05:05","pubTimestamp":1760821514,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，澳华内镜报收于46.35元，较上周的49.8元下跌6.93%。本周，澳华内镜10月14日盘中最高价报52.63元。2025年7月8日，公司披露减持计划，君联欣康与高燊拟合计减持不超过2,581,774股，通过集中竞价和大宗交易方式实施。截至2025年10月13日，减持计划时间届满，两者已通过集中竞价减持1,346,574股，大宗交易减持1,235,200股，合计减持2,581,774股，占总股本1.92%，减持价格区间为45.21～54.25元/股，减持总金额125,576,942.78元，当前持股数量为0股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900001113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"gpt_icon":0},{"id":"2575264910","title":"10月14日澳华内镜跌5.64%，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2575264910","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575264910?lang=zh_cn&edition=full","pubTime":"2025-10-14 16:15","pubTimestamp":1760429744,"startTime":"0","endTime":"0","summary":"证券之星消息，10月14日澳华内镜跌5.64%，收盘报48.2元，换手率2.39%，成交量3.21万手，成交额1.59亿元。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共28家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为36.45亿元，最新净值3.3667，较上一交易日下跌0.82%，近一年上涨41.68%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101400051316.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","BK0251"],"gpt_icon":0},{"id":"2571356778","title":"股市必读：9月29日澳华内镜现6笔折价10.03%的大宗交易 合计成交1651.07万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2571356778","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571356778?lang=zh_cn&edition=full","pubTime":"2025-09-30 01:13","pubTimestamp":1759165994,"startTime":"0","endTime":"0","summary":"截至2025年9月29日收盘，澳华内镜报收于50.25元，上涨2.26%，换手率2.2%，成交量2.96万手，成交额1.49亿元。当日关注点来自交易信息汇总：9月29日主力资金净流入1703.32万元，占总成交额11.47%。大宗交易9月29日澳华内镜现6笔折价10.03%的大宗交易，合计成交1651.07万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025093000001033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"gpt_icon":0},{"id":"2571808301","title":"华安证券：给予澳华内镜买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2571808301","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571808301?lang=zh_cn&edition=full","pubTime":"2025-09-29 12:18","pubTimestamp":1759119539,"startTime":"0","endTime":"0","summary":"华安证券股份有限公司谭国超,李婵近期对澳华内镜进行研究并发布了研究报告《上半年业务持续承压，预计下半年修复》，给予澳华内镜买入评级。目前软镜行业中外资企业的市场占有率仍较高，尤其是三级医院，国产可替代空间较大。最新盈利预测明细如下：该股最近90天内共有14家机构给出评级，买入评级8家，增持评级6家；过去90天内机构目标均价为59.63。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900012752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688212","600909"],"gpt_icon":0},{"id":"2569575334","title":"澳华内镜公布国际专利申请：“内窥镜系统的光源装置及内窥镜系统”","url":"https://stock-news.laohu8.com/highlight/detail?id=2569575334","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569575334?lang=zh_cn&edition=full","pubTime":"2025-09-23 05:25","pubTimestamp":1758576342,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示澳华内镜（688212）公布了一项国际专利申请，专利名为“内窥镜系统的光源装置及内窥镜系统”，专利申请号为PCT/CN2024/144530，国际公布日为2025年9月18日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来澳华内镜已公布的国际专利申请1个。结合公司2025年中报财务数据，今年上半年公司在研发方面投入了7380.91万元，同比减15.49%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092300003459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"gpt_icon":0},{"id":"2569246152","title":"每周股票复盘：澳华内镜（688212）现7笔大宗交易机构净买入1392.89万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2569246152","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569246152?lang=zh_cn&edition=full","pubTime":"2025-09-21 04:24","pubTimestamp":1758399852,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，澳华内镜报收于48.93元，较上周的49.22元下跌0.59%。本周，澳华内镜9月16日盘中最高价报52.38元。交易信息汇总9月16日澳华内镜发生7笔大宗交易，机构席位合计净买入1392.89万元。公司公告汇总上海市通力律师事务所就上海澳华内镜股份有限公司2025年第二次临时股东大会出具法律意见书。上海市通力律师事务所见证并出具法律意见书，确认本次股东大会召集、召开程序合法，表决结果有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100001095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688212"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1764958223247,"stockEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0061},{"period":"3month","weight":-0.001},{"period":"6month","weight":-0.1452},{"period":"1year","weight":0.0233},{"period":"ytd","weight":0.1888}],"compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0167},{"period":"3month","weight":0.0237},{"period":"6month","weight":0.1529},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1644}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海澳华内镜股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"5549人(较上一季度增加41.52%)","perCapita":"24268股","listingDate":"2021-11-15","address":"上海市闵行区光中路133弄66号","registeredCapital":"13466万元","survey":" 上海澳华内镜股份有限公司的主营业务是电子内窥镜设备及内窥镜诊疗手术耗材研发、生产和销售。公司的主要产品是内窥镜设备、内窥镜诊疗耗材、内窥镜维修服务。","listedPrice":22.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"澳华内镜(688212)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供澳华内镜(688212)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"澳华内镜,688212,澳华内镜股票,澳华内镜股票老虎,澳华内镜股票老虎国际,澳华内镜行情,澳华内镜股票行情,澳华内镜股价,澳华内镜股市,澳华内镜股票价格,澳华内镜股票交易,澳华内镜股票购买,澳华内镜股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"澳华内镜(688212)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供澳华内镜(688212)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}